The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© 2023 AFPTrial of new COVID treatment yields encouraging results: study
WASHINGTON©2024 GPlusMedia Inc.
The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© 2023 AFP
5 Comments
Login to comment
Speed
Good news. Hopefully, effective treatment will help us get rid of the need for vaccinations.
Maria
Why was it originally rejected by the FDA? How much does it cost? Japan currently relies on Lagevrio (not Paxlovid) which have been shown to create new variants.
Raw Beer
Promising, but considering how mild the virus has gotten, many would need to get this injection to prevent one hospitalization. I hope it's cheap, but I doubt it.
Plus, we already have a number of very safe and cheap early treatments that are at least as effective as this one.
virusrex
Other reports give some extra details, but general speaking borderline evidence, lack of interest and invlid criticism from antiscientific sources against everything that was approved by emergency use are important reasons. The FDA ended up not approving several things that could have had usefulness including lambda interferon.
Unfortunately the ones you keep trying to push (HCQ and ivermectin) are the opposite, they offer no benefit and instead subject the patients to extra risks even to their lives, this on the other side have strong scientific evidence of benefit which of course make it a very useful tool specially for patients at high risk of complication, and hopefully it will save a lot of lives.
theResident
Oh, here we go, Raw Beer pushing IVM and HCQ again, despite having been proved rubbish. Give it up.